Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
Laloi, Louise, Billotey, Natacha Chaumard, Dumas, Pierre‐Yves, Paul, Franciane, Villate, Alban, Simand, Célestine, Fornecker, Luc, Puisset, Florent, Bertoli, Sarah, Simonet, Marion Boissard, Laribi, Kamel, Houyou, Dyhia, Santagostino, Alberto, Michel, Claire, Guepin, Gabrielle Roth, Guerineau, Elodie, Tabrizi, Reza, Hunault, Mathilde, Giltat, Aurélien, Kaphan, Eléonore, Bulabois, Claude, Cartet, Elodie, Rocher, Clément, Lachenal, Florence, Morisset, Stéphane, Récher, Christian, Pigneux, Arnaud, Belhabri, Amine, Michallet, Mauricette, Michallet, Anne‐Sophie
Published in Cancer medicine (Malden, MA) (01.03.2023)
Published in Cancer medicine (Malden, MA) (01.03.2023)
Get full text
Journal Article
Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016—1Q2021
Chappuy, Mathieu, Nourredine, Mikail, Clerc, Bertrand, Fahmi, Morgan, Misslin, Pauline, Berthier, Maude, Laloi, Louise, Rolland, Benjamin
Published in Fundamental & clinical pharmacology (01.04.2022)
Published in Fundamental & clinical pharmacology (01.04.2022)
Get full text
Journal Article